Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression, Cell Mol Biol Lett, vol.12, pp.127-138, 2007. ,
Apelin, a newly identified adipokine upregulated by insulin and obesity, Endocrinology, vol.146, pp.1764-1771, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00480981
Castan-Laurell I. Expanding role for the apelin/APJ system in physiopathology, J Physiol Biochem, vol.63, pp.359-373, 2007. ,
Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ, Eur J Endocrinol, vol.158, pp.905-910, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00277309
Adipokines in the treatment of diabetes mellitus and obesity, Expert Opin Pharmacother, vol.10, pp.239-254, 2009. ,
The role of apelin in cardiovascular function and heart failure, Eur J Heart Fail, vol.10, pp.725-732, 2008. ,
Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients, Diabetologia, vol.47, pp.917-925, 2004. ,
Apelin stimulates glucose utilization in normal and obese insulinresistant mice, Cell Metab, vol.8, pp.437-445, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00408948
Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes, Diabetes, vol.50, pp.1134-1142, 2001. ,
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus, Exp Clin Endocrinol Diabetes, vol.116, pp.289-292, 2008. ,
Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding, Regul Pept, vol.130, pp.7-13, 2005. ,
Effect of dietinduced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome, Nutr Metab Cardiovasc Dis, vol.19, pp.626-633, 2009. ,
Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system, J Mol Cell Cardiol, vol.41, pp.798-806, 2006. ,
Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus, Metabolism, vol.59, pp.373-379, 2009. ,
Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance, Arterioscler Thromb Vasc Biol, vol.28, 1982. ,
Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle, J Clin Invest, vol.98, pp.43-49, 1996. ,
Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects, Exp Clin Endocrinol Diabetes, vol.114, pp.544-548, 2006. ,
Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people, Diabetes Care, vol.32, p.150, 2009. ,
Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes, Mol Med, vol.6, pp.680-692, 2000. ,
Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha, J Biol Chem, vol.278, pp.52298-52306, 2003. ,
Apelin levels are increased in morbidly obese subjects with Type 2 Diabetes Mellitus, Obes Surg, vol.19, pp.1574-1580, 2009. ,
Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor, Biochem Biophys Res Commun, vol.251, pp.471-476, 1998. ,
Apelin is necessary for the maintenance of insulin sensitivity, Am J Physiol Endocrinol Metab, vol.298, pp.59-67, 2010. ,
Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice, Cardiovasc Res, vol.74, pp.388-395, 2007. ,